Mechanisms of structural plasticity, client interactions, and co-aggregation of the lens ⍺-crystallins
晶状体α-晶状体的结构可塑性、客户相互作用和共聚集机制
基本信息
- 批准号:10709482
- 负责人:
- 金额:$ 3.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
The ⍺-crystallins (⍺A- and ⍺B- isoforms) are essential for the development and lifelong transparency of the eye
lens. As molecular chaperones – members of the small heat shock protein family – the ⍺-crystallins play an
integral part of the stability of lens proteostasis and preventing the formation of age-related opacities (i.e., protein
aggregates) responsible for cataract formation. However, this system may become destabilized and/or
overwhelmed as a result of the long-lived nature of lens proteins, and ultimately contribute to disease
progression. Despite these fundamental roles in lens transparency and disease, there remains a critical gap in
our understanding of the molecular mechanisms by which the ⍺-crystallins function, and how these proteins
aggregate in response to aberrant (or age-related) conditions in the lens. A hallmark feature of the ⍺-crystallins
is a remarkable degree of structural plasticity that is driven by sub-domain interactions involving flexible N- and
C-termini, a feature that is thought to prevent crystallization under the highly concentrated environment of the
eye lens. This molecular plasticity also contributes to ⍺-crystallin chaperone function, allowing it to adapt to and
sequester a diverse range of destabilized proteins (aka clients) and prevent cytotoxic aggregation. However,
these same features of intrinsic dynamics have stymied previous efforts to obtain the detailed structural
characterizations (atomistic details) required to provide mechanistic insights into the function of these critical
components of the eye lens. The aims of this proposal will leverage recent advances in the state-of-the-art
methods of single particle CryoEM cryo-electron tomography (CryoET) – coupled with biophysical and functional
studies – in order to obtain high-resolution structural information regarding the mechanism of ⍺-crystallin
structural plasticity/polydispersity (Aim 1). Additional insights into the pathway(s) of chaperone/client co-
aggregation (Aim 2) will be garnered from NSEM, light scattering, and crosslinking-MS/MS methods. Success of
these aims will fill critical gaps in knowledge that have evaded the field for decades and provide detailed
mechanistic insights into the molecular basis of ⍺-crystallin’s hallmark of structural plasticity and how the lens
chaperone system becomes overwhelmed leading to cytotoxic protein aggregates such as those found in
cataract.
项目摘要
⍺-晶状体(⍺a-和⍺b-同工型)对于眼睛的发育和终身透明度至关重要
镜片。作为分子伴侣 - 小热冲击蛋白家族的成员 - ⍺晶状蛋白会发挥
晶状体蛋白抑制剂稳定性的整体部分,并防止与年龄相关的OCACITITS的形成(即蛋白质
聚集体)负责白内障形成。但是,该系统可能变得不稳定和/或
由于晶状体蛋白的长期性质而淹没,并最终导致疾病
进展。尽管在晶状体透明度和疾病中具有这些基本作用,但仍存在关键的差距
我们对⍺-晶状蛋白起作用的分子机制的理解,以及这些蛋白质如何
⍺-Crystallins的标志性功能
是一个显着程度的结构可塑性,由亚域相互作用驱动,涉及柔性n-和
C-termini,该功能被认为可以防止在高度集中环境下结晶
眼镜镜头。该分子可塑性也有助于⍺-晶状蛋白链烯唯一功能,从而使其适应和适应
隔离一系列不稳定的蛋白质(又称客户端),并防止细胞毒性聚集。然而,
这些内在动力学的相同特征已经阻碍了以前的努力来获得详细的结构
为这些关键的功能提供机械见解所需的字符(原子细节)
眼镜的组成部分。该提案的目的将利用最新的最新进展
单个粒子冷冻冷冻电子层析成像(冷冻)的方法 - 与生物物理和功能
研究 - 为了获得有关⍺-晶状体机制的高分辨率结构信息
结构可塑性/多分散性(AIM 1)。对伴侣/客户端共同的途径的其他见解
聚集(AIM 2)将从NSEM,光散射和交联MS/MS方法中获得。成功
这些目标将填补数十年来逃避该领域并提供详细信息的关键空白
对⍺-晶状体的结构可塑性标志的分子基础的机械洞察力以及镜头的方式
伴侣系统变得不知所措,导致细胞毒性蛋白聚集体,例如在
白内障。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Adam Phillip Mille...的其他基金
Mechanisms of structural plasticity, client interactions, and co-aggregation of the lens ⍺-crystallins
晶状体α-晶状体的结构可塑性、客户相互作用和共聚集机制
- 批准号:1046314410463144
- 财政年份:2022
- 资助金额:$ 3.95万$ 3.95万
- 项目类别:
相似国自然基金
纤溶酶原结合蛋白Tetranectin通过抑制梭形菌的肠道内定植介导肠黏膜炎症相关疾病发展的机制研究
- 批准号:82370540
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
钙结合蛋白S100A4通过RAGE-PPARg调控肥大细胞代谢及其对过敏性疾病的作用
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
RNA结合蛋白进入线粒体的稳态调控机制及其在神经退行性疾病中的作用
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
基于皮肤荧光结合平行因子分析技术的老年性疾病早期预警方法研究
- 批准号:62205345
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多聚(ADP-核糖)聚合酶PARP调控疾病相关RNA结合蛋白的细胞和分子机理研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:1075255510752555
- 财政年份:2024
- 资助金额:$ 3.95万$ 3.95万
- 项目类别:
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:1055754710557547
- 财政年份:2023
- 资助金额:$ 3.95万$ 3.95万
- 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:1067834110678341
- 财政年份:2023
- 资助金额:$ 3.95万$ 3.95万
- 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:1067878910678789
- 财政年份:2023
- 资助金额:$ 3.95万$ 3.95万
- 项目类别:
Regulation of paraspeckles by STAU1 in neurodegenerative disease
STAU1 在神经退行性疾病中对 paraspeckles 的调节
- 批准号:1066802710668027
- 财政年份:2023
- 资助金额:$ 3.95万$ 3.95万
- 项目类别: